Cargando…
Facial Basal Cell Carcinoma Treated with Topical 5% Imiquimod Cream with Dermoscopic Evaluation
Basal cell carcinoma (BCC) is the most common skin cancer worldwide. Surgical excision is considered to be the primary therapeutic modality wherever possible. For inoperable cases, 5% imiquimod seems to be a good alternative. We present two cases of nodular pigmented BCCs on the face in elderly wome...
Autores principales: | Singal, Archana, Daulatabad, Deepashree, Pandhi, Deepika, Arora, VK |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4924409/ https://www.ncbi.nlm.nih.gov/pubmed/27398014 http://dx.doi.org/10.4103/0974-2077.184040 |
Ejemplares similares
-
PIGMENTED BASAL CELL CARCINOMA SUCCESSFULLY TREATED WITH 5% IMIQUIMOD CREAM
por: Mehta, Vandana, et al.
Publicado: (2008) -
Successful Treatment of Giant Basal Cell Carcinoma with Topical Imiquimod 5% Cream with Long Term Follow-up
por: Chun-Guang, M, et al.
Publicado: (2014) -
Treatment of Cutaneous Tumors with Topical 5% Imiquimod Cream
por: Alessi, Sabrina Sisto, et al.
Publicado: (2009) -
Graying severity score: A useful tool for evaluation of premature canities
por: Singal, Archana, et al.
Publicado: (2016) -
Reflectance Confocal Microscopy Follow-up of Multifocal Superficial Basal Cell Carcinomas Treated With Imiquimod 5% Cream
por: Zou, Yunmin, et al.
Publicado: (2022)